Skip to main content

Trip Taylor

Head of Investor Relations

Pulse Biosciences, Inc. (PLSE)

Equibles does not estimate personal net worth.

Get an email with a short summary when Pulse Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.

Get PLSE alerts

About Trip Taylor

Trip Taylor is recorded as Head of Investor Relations at Pulse Biosciences, Inc. (PLSE). Trip Taylor has spoken on 6 earnings calls across 1 company, most recently for Pulse Biosciences, Inc. on August 6, 2026. Pulse Biosciences, Inc. is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Pulse Biosciences, Inc. includes Burke T. Barrett (CEO and Board Member), Kevin Danahy (CEO), Paul A. LaViolette (CEO, Chairman and Board Member) and 7 others.

Trip Taylor on recent calls

“Before we begin, I'd like to inform you that comments and responses to your questions during today's call reflect management's views as of today, August 6, 2026 only, and will include forward-looking statements and opinion statements, including predictions, estimates, plans, expectations, and other similar information.”
Head of Investor Relations, Pulse Biosciences Schedules Second Quarter 2026 Financial Results Conference Call for August 6, 2026 ·
“Before we begin, I'd like to inform you that comments and responses to your questions during today's call reflect management's views as of today, May 7, 2026 only, and will include forward-looking statements and opinion statements, including predictions, estimates, plans, expectations, and other similar information.”
Head of Investor Relations, Pulse Biosciences, Inc. Q1 FY2026 Earnings Call ·
“Before we begin, I'd like to inform you that comments and responses to your questions during today's call reflect management's views as of today, February 19, 2026 only, and will include forward-looking statements and opinion statements, including predictions, estimates, plans, expectations, and other similar…”
Head of Investor Relations, Pulse Biosciences, Inc. Q4 FY2025 Earnings Call ·
“Before we begin, I would like to inform you that comments and responses to your questions during today's call reflect management's views as of today, October 30th, 2024 only and will include forward-looking statements and opinion statements, including predictions, estimates, plans, expectations, and other similar…”
Head of Investor Relations, Pulse Biosciences, Inc. Q3 FY2024 Earnings Call ·
“Before we begin, I would like to inform you that comments and responses to your questions during today's call reflect management's views as of today, May 11, 2023, only and will include forward-looking statements and opinion statements including predictions, estimates, plans, expectations, and other information.”
Head of Investor Relations, Pulse Biosciences, Inc. Q1 FY2023 Earnings Call ·

Affiliation history

Company network

Leadership on record at Pulse Biosciences, Inc.

Recent activity